Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SW033291 是有效的15-PGDH 抑制剂,与15-PGDH 亲和力高,Ki 为 0.1 nM。它增加骨髓和其他组织中前列腺素 PGE2 的水平。它还可促进组织再生。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 297 | 现货 | ||
2 mg | ¥ 439 | 现货 | ||
5 mg | ¥ 719 | 现货 | ||
10 mg | ¥ 1,170 | 现货 | ||
25 mg | ¥ 2,190 | 现货 | ||
50 mg | ¥ 3,260 | 现货 | ||
100 mg | ¥ 4,770 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 655 | 现货 |
产品描述 | SW033291 is a small-molecule inhibitor of 15-PGDH (Ki=0.1 nM) that increases prostaglandin PGE2 levels in bone marrow and other tissues. |
靶点活性 | 15-PGDH:0.1 nM(Ki), 15-PGDH:1.5 nM |
体外活性 | In Vaco-503 cells, SW033291 (2.5 μM) decreases cellular 15-PGDH enzyme activity by 85%.[1] |
体内活性 | In mice receiving a bone marrow transplant, SW033291 (10 mg/kg, i.p.) promotes hematopoietic recovery. In mouse models of colon and liver injury, SW033291 (10 mg/kg, i.p.) reduces the levels of colitis-associated inflammatory cytokines, protects mice from colitis, and promotes liver regeneration. [1] |
激酶实验 | Fluorescence anisotropy (FP) ligand displacement assay: All components are dissolved in buffer of composition 50 mM HEPES pH 7.4, 150 mM NaCl and 0.5 mM CHAPS with final concentrations of BRD 2/3/4 75 nM, fluorescent ligand 5 nM. 10 μL of this reaction mixture is added using a micro multidrop to wells containing 100 nL of various concentrations of I-BET151 or DMSO vehicle (1% final) in Greiner 384 well Black low volume microtitre plate and equilibrated in the dark for 60 minutes at room temperature. Fluorescence anisotropy is read in Envision (lex = 485 nm, lEM = 530 nm; Dichroic = 505 nM). |
分子量 | 412.59 |
分子式 | C21H20N2OS3 |
CAS No. | 459147-39-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41.3 mg/mL (100 mM)
Ethanol: 8.3 mg/mL (20 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / Ethanol | 1 mM | 2.4237 mL | 12.1186 mL | 24.2371 mL | 60.5928 mL |
5 mM | 0.4847 mL | 2.4237 mL | 4.8474 mL | 12.1186 mL | |
10 mM | 0.2424 mL | 1.2119 mL | 2.4237 mL | 6.0593 mL | |
20 mM | 0.1212 mL | 0.6059 mL | 1.2119 mL | 3.0296 mL | |
DMSO | 50 mM | 0.0485 mL | 0.2424 mL | 0.4847 mL | 1.2119 mL |
100 mM | 0.0242 mL | 0.1212 mL | 0.2424 mL | 0.6059 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
SW033291 459147-39-8 Metabolism Dehydrogenase knockout PGE2 15-PGDH Peripheral prostaglandin bone inhibit neutrophil SW-033291 SW 033291 hematopoietic 15-Hydroxyprostaglandin dehydrogenase marrow Inhibitor inhibitor